From last NP interview: We articulated to have
Post# of 148177
(Total Views: 604)
Posted On: 07/21/2020 11:18:20 AM
From last NP interview:
So, a good possibility is that the efficacy data will be released together with the S/C interim peek.
That would explain why the data has not been reported yet (they are taking the time necessary to synchronize with S/C).
Just a thought. No way to probe it one way or another.
Quote:
We articulated to have a look at the results of S/C at the same time to be able to give FDA some results so they can make a decision, can we make an exception and make emergency approval immediately, or there is something else we need to do.
So, a good possibility is that the efficacy data will be released together with the S/C interim peek.
That would explain why the data has not been reported yet (they are taking the time necessary to synchronize with S/C).
Just a thought. No way to probe it one way or another.
(3)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼